Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Update on the European Vasculitis Study Group trials
Autore:
Jayne, D;
Indirizzi:
St Helier Hosp, Renal Unit, Surrey SM5 1AA, England St Helier Hosp Surrey England SM5 1AA enal Unit, Surrey SM5 1AA, England
Titolo Testata:
CURRENT OPINION IN RHEUMATOLOGY
fascicolo: 1, volume: 13, anno: 2001,
pagine: 48 - 55
SICI:
1040-8711(200101)13:1<48:UOTEVS>2.0.ZU;2-J
Fonte:
ISI
Lingua:
ENG
Soggetto:
ANTINEUTROPHIL CYTOPLASMIC ANTIBODY; SYSTEMIC NECROTIZING VASCULITIS; CHURG-STRAUSS-SYNDROME; WEGENERS-GRANULOMATOSIS; PULSE CYCLOPHOSPHAMIDE; MICROSCOPIC POLYANGIITIS; POLYARTERITIS-NODOSA; RENAL INVOLVEMENT; RANDOMIZED TRIAL; PLASMA-EXCHANGE;
Tipo documento:
Review
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Citazioni:
69
Recensione:
Indirizzi per estratti:
Indirizzo: Jayne, D St Helier Hosp, Renal Unit, Surrey SM5 1AA, England St Helier Hosp Surrey England SM5 1AA , Surrey SM5 1AA, England
Citazione:
D. Jayne, "Update on the European Vasculitis Study Group trials", CURR OP RH, 13(1), 2001, pp. 48-55

Abstract

Over the last fifteen years, collaborative vasculitis studies in Europe have established the association of antineutrophil cytoplasmic antibodies (ANCA) with vasculitis and defined its clinical role as a diagnostic tool. More recently, the European Vasculitis Study Group has developed a consensus approach to the treatment of vasculitis and has aimed to harmonize and optimize current therapy by a series of multicenter randomized controlled trials. The first trial to report, CYClophosphamide or AZathioprine As a REMission therapy for vasculitis (CYCAZAREM), demonstrated that, for generalized vasculitis, azathioprine is as effective as continued cyclophosphamide for the maintenance of remission. Other trials are investigating the roles of methotrexate, plasma exchange, and pulse cyclophosphamide in acute disease, and strategies to prevent relapse over the longer term. Parallel studies are determining prognostic markers, evaluating tools for monitoring disease, and examining the association of ANCA and infection with relapse. The established infrastructure and accumulated database are well placed to facilitate testing of newer therapeutic strategies in the future. Curr Opin Rheumatol 2001, 13:48-55 (C) 2001 Lippincott Williams & Wilkins, Inc.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 25/11/20 alle ore 18:32:51